Stocktoria
PAVmed Inc. PAVM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-07-27
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $71,000 | $3.0M | $2.5M | $377,000 | $500,000 |
| Gross profit | — | — | — | — | -$85,000 |
| Operating income | -$21.8M | -$44.5M | -$68.8M | -$91.1M | -$54.4M |
| Net income | $401,000 | $39.8M | -$64.2M | -$89.0M | -$50.3M |
| Operating cash flow | -$5.2M | -$33.6M | -$52.0M | -$71.0M | -$40.6M |
| Free cash flow | -$5.2M | -$33.6M | -$52.3M | -$72.5M | -$42.1M |
| Total assets | $38.8M | $30.7M | $33.1M | $54.0M | $87.0M |
| Total liabilities | $16.5M | $37.7M | $57.1M | $43.0M | $7.6M |
| Shareholders' equity | $22.3M | -$7.0M | -$24.0M | $10.9M | $79.4M |
| Ratios | |||||
| Gross margin | — | — | — | — | -17.0% |
| Operating margin | -30712.7% | -1485.4% | -2805.7% | -24161.0% | -10878.6% |
| Net margin | 564.8% | 1328.6% | -2617.3% | -23602.9% | -10069.4% |
| FCF margin | -7376.1% | -1122.2% | -2132.1% | -19237.4% | -8412.0% |
| Return on assets | 1.0% | 129.8% | -193.8% | -164.8% | -57.9% |
| Return on equity | 1.8% | -565.8% | 267.2% | -813.8% | -63.4% |
| Current ratio | 0.17 | 0.06 | 0.45 | 1.07 | 10.93 |
| Revenue growth | -97.6% | 22.1% | 550.4% | -24.6% | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001624326 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.